Access to premium content is restricted to healthcare professionals / registered members. Login with your email address to continue.
Forgot Your Password?
Follow Topic
Bookmark
Johnson & Johnson today said it has taken on responsibility for the sales, marketing and distribution of the medicines in the UK.
17 Oct 2024
Elafibranor (Iqirvo) has been approved by the MHRA to treat adult patients with a rare type of liver disease known as primary biliary cholangitis
08 Oct 2024
People with type 2 diabetes are prone to developing asthma and vice versa, according to recent analysis.
04 Oct 2024
Pain seems to be the most common and severe long Covid symptom, according to a new retrospective analysis.
05 Sep 2024
Pharmacy could not give patient's prescribed strength of EpiPen in fatal anaphylaxis case.
04 Sep 2024
NHS data shows that 487,432 people in England were living with diagnosed dementia in June 2024 — the highest number on record.
08 Aug 2024
Rates of polypharmacy and potentially inappropriate prescribing are lower in the UK than in many European countries, a new analysis has revealed.
29 Jul 2024
Problematic NSAID prescribing costs NHS England an estimated £31m over 10 years, says a new study.
26 Jul 2024
Each of the six courses includes case studies and skin examination advice.
23 Jul 2024
Antibiotics seem to increase the risk of fibromyalgia up to four-fold, according to recent primary care data.
08 Jul 2024
Rising rates of other cardiovascular diseases have offset much of a decline in coronary heart disease.
05 Jul 2024
Migraine and antiseizure medication topiramate (Topamax) must no longer be prescribed to women and girls unless they fulfil the requirements of a Pregnancy Prevention Programme
24 Jun 2024
Researchers in the US are warning that parental vaping exacerbates atopic dermatitis in children.
10 Jun 2024
Semaglutide can produce weight loss and reduce waist size for at least four years, says new research.
06 Jun 2024
Deaths from non-melanoma skin cancer could soon overtake malignant melanoma mortality in England and Scotland.
Sanofi recently launched an inactivated rabies vaccine (Verorab) in the UK for all age groups.
20 May 2024
